hTERT Gene Expression in Gliomas
Author Information
Author(s): Tchirkov A, Rolhion C, Kémény J-L, Irthum B, Puget S, Khalil T, Chinot O, Kwiatkowski F, Périssel B, Vago P, Verrelle P
Primary Institution: Centre Jean Perrin, Clermont-Ferrand, France
Hypothesis
The study evaluates the correlation between hTERT gene expression and the malignancy grade of gliomas.
Conclusion
hTERT expression increases with the malignancy grade of gliomas and is predictive of patient survival in glioblastoma multiforme.
Supporting Evidence
- hTERT expression was found in 7.1% of low-grade gliomas, 30.8% of anaplastic gliomas, and 69.8% of GBMs.
- Patients with high hTERT levels had significantly shorter survival compared to those with low levels.
- The study used a sample size of 70 glioma patients to assess hTERT mRNA levels.
Takeaway
This study looked at a gene called hTERT in brain tumors and found that higher levels of this gene mean the tumors are more dangerous and patients may not live as long.
Methodology
Real-time quantitative PCR was used to measure hTERT mRNA levels in tumor samples from glioma patients.
Limitations
The study did not include patients with gross total tumor excision, which may influence survival outcomes.
Participant Demographics
46 male and 24 female patients with a mean age of 31.5 years for low-grade, 43.7 years for anaplastic, and 59.5 years for GBM.
Statistical Information
P-Value
p=0.00024
Statistical Significance
p=0.00003
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website